Registry Study on "Control Nocturnal Hypertension to Reach the Target "

Launched by SHANGHAI INSTITUTE OF HYPERTENSION · Oct 22, 2019

Keywords

ClinConnect Summary

This clinical trial is studying how to better manage high blood pressure that occurs at night, known as nocturnal hypertension. Researchers are interested in understanding whether controlling blood pressure during the night can lead to better heart health outcomes for people who have high blood pressure. They are using a special method called ambulatory blood pressure monitoring (ABPM), which allows doctors to measure blood pressure continuously over 24 hours, including while participants sleep. The goal is to find out if lowering nighttime blood pressure can help reduce the risk of serious heart problems like heart attacks and strokes.

To be eligible for this study, participants should be between 50 to 79 years old, currently taking medication for high blood pressure, and have been diagnosed with nocturnal hypertension (meaning their blood pressure is higher than normal while they sleep). They will need to agree to share their medical history and recent blood test results. Those who are already hospitalized for high blood pressure or not using medication will not be included. Participants can expect to be monitored closely and contribute to important research that could improve treatment for others with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 50-79 years old
• • Clinical diagnosed hypertension with the use of antihypertensive drugs
• • Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg)
• • A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
• • Willing to provide information about disease history and blood biochemical test data within 6 months.
• • Sign the informed consent
• Exclusion Criteria:
• • Without antihypertensive drug use
• • Hospitalized hypertension patients
• • Non-compliant patient